Ethyl Pyruvate Protects against Lethal Systemic Inflammation by Preventing HMGB1 Release
- 1 April 2003
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 987 (1), 319-321
- https://doi.org/10.1111/j.1749-6632.2003.tb06075.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in ratsCritical Care Medicine, 2001
- Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learnedCritical Care Medicine, 2001
- SEPTIC STOCKPediatric Clinics of North America, 2001
- Current treatment of sepsis and endotoxaemiaExpert Opinion on Pharmacotherapy, 2000
- Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shockThe Lancet, 1999
- HMG-1 as a Late Mediator of Endotoxin Lethality in MiceScience, 1999